Trial Profile

A Multicenter, Open Phase I Clinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Initial Efficacy of BAT8008 for Injection in Patients With Advanced Solid Tumor

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 12 Feb 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BAT 8008 (Primary)
Indications Carcinoma; Solid tumours
Focus Adverse reactions
Sponsors Bio-Thera Solutions

Most Recent Events

09 Feb 2026 Planned End Date changed from 1 Dec 2025 to 31 May 2027.
09 Feb 2026 Planned primary completion date changed from 1 Oct 2024 to 31 May 2027.
14 Apr 2025 According to Bio-Thera Solutions media release, data from this study will be presented at at the 2025 ASCO Annual Meeting

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com